49例宫颈腺癌临床病理及诊断分析

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (4090 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To investigate the clinical and pathological features of cervical adenocarcinoma and analyze the relevant factors which leading to misdiagnosis and missed diagnosis, aimed at early diagnosis and affirm the histological type. Methods: Clinical and pathological data of 49 cases of cervical adenocarcinoma patients, comprehensive combing the treatment and diagnosis process of all cases were retrespefively analyzed. Results: The cervical adenocarcinoma percentage of cervical cancer was 20.47% and 10.11% in 2011～2013 and 2005～2007. The main clinical symptoms of cervical adenocarcinoma were vaginal bleeding, fluid flow and increased vaginal discharge. Liquid-based cytology false negative rate was 28.57% (18/49). High-risk HPV positive rate was 93.88% (46/49). The first biopsy-confirmed cases were only 21 cases (46.94%). The pathology grossly type was mainly about nodular polypoid or endophyte, but that there were 11 cases (22.45%) was cervicitis or cervical smooth performance. The mucinous adenocarcinoma was the most to see of histology. Immunohistochemical CEA, P16 and P53 were positive. Conclusion: The meyority of clinicd syrptoms of the cervical adenocarcinama was non-specific. Utilization ofliquid-based cytology, high-risk HPV testing, colposcopy, cervical cone biopsy and immunohistochemical examination and other means to effectively master a variety of diagnostic genotyping points is the key to reducing misdiagnosis and miss diagnosis. Suggested that cervical conization as a diagnostic method for the micro-deviation adenocarcinoma, fluff tubular adenocarcinoma, cervical adenocarcinoma and early invasive adenocarcinoma.

Key words： uterine cervical neoplasms pathology diagnosis misdiagnosis typing

Received: 19 February 2014

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	JIN Xinhong1
	WENG Ke2
	WANG Shanshan3
	HUANG Bifei4.

URL:

https://xb.wmu.edu.cn/EN/ OR https://xb.wmu.edu.cn/EN/Y2015/V45/I4/290

[1] Mathew A, George PS. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix-worldwide[J]. Asian Pac J Cancer Prev, 2009, 10(4): 645-650.
[2] 邹琳, 兰建云, 耿建祥, 等. 47例宫颈腺癌中人乳头状瘤病毒感染基因分型的研究[J]. 国际检验医学杂志, 2013, 34 (4): 393-397.
[3] Gong L, Zhang WD, Liu XY, et al. Clonal status and clinic pathological observation of cervical minimal deviation adenocarcinoma[J]. Diagn Pathol, 2010(5): 25.
[4] Lee YY, Choi CH, Kim TJ, et al. A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA[J]. Gynecol Oncol, 2011,120: 439-443.
[5] An HJ, Kim KR, Kim IS, et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study[J]. J Mod Pathol,2005, 18(4): 528-534.
[6] 张建新, 张长淮, 周艳秋, 等. 15 393例宫颈液基细胞学与组织病理学的对照分析[J]. 中华病理学杂志, 2007, 36(7): 485-488.
[7] Crum CP, Lee KR. 妇产科诊断病理学[M]. 回允中主译. 北京: 北京大学出版社, 2007: 357-384.
[8] 张金库, 张浙岩. 子宫颈液基细胞学诊断图谱[M]. 北京: 人民军医出版社, 2006: 15.
[9] Robby SJ, Anderson MC, Russell P. 女性生殖道病理学[M]. 回允中主译. 北京: 北京大学医学出版社, 2005: 224.
[10] 李彦敏, 周奕琳, 郭雪西, 等. 粗针活检诊断子宫颈微偏腺癌4例及临床病理分析[J]. 临床与实验病理学杂志, 2011, 27(6): 623.
[11] 胡应光, 董世蓉, 汪露祥. 子宫颈微偏腺癌6例临床病理分析[J]. 临床与实验病理学杂志, 2005, 20(4): 430-432.
[12] 闫鼎, 吕晓娟, 徐小仙, 等. 宫颈微偏腺癌10例临床诊治及病理学分析[J]. 浙江医学, 2012, 34(16): 1377-1379.
[13] Korach J, Machtinger R, Perri T, et al. Villoglandular papillary adenocarcinoma of the uterine cervix: a diagnostic challenge[J]. Acta Obstet Gynecol Scand, 2009, 88(3): 355-358.
[14] Gonzalez-Bosquet E, Sunol M, Morante D, et al. Villoglandular papillary adenocarcinoma of the uterine cervix: a case report and literature review[J]. Eur J Gynaecol Oncol, 2009, 30(2): 211-213.